{
  "book_page": 114,
  "pdf_page": 58,
  "content": {
    "main_concept": "Isoniazid (INH) causes hepatotoxicity",
    "key_points": "- **Isoniazid is an antituberculosis agent**\\n- **It is best taken on an empty stomach**\\n- **Report tingling sensation in the lower extremities** - It indicates peripheral neuropathy\\n- **Avoid alcohol**\\n- **Liver function studies should be done before the start of therapy**\\n- **Therapeutic effects generally occur in 2 â€“ 3 weeks**\\n- **Administer with Vitamin B6 to prevent peripheral neuropathy**",
    "questions": [
      {
        "id": 1,
        "type": "multiple_choice",
        "question_text": "In a client receiving isoniazid (INH), which of the following laboratory data needs to be reported to the physician?",
        "options": [
          "1. Urine output of 30 ml/hr",
          "2. Elevated AST and ALT",
          "3. Serum potassium level of 3.7 mEq/L",
          "4. Decreased blood pressure"
        ],
        "correct_answer": "2",
        "rationale": "**RATIONALE**\\n\\nElevated AST and ALT levels are indicative of drug-induced hepatitis, a common side effect of isoniazid."
      }
    ]
  },
  "images": [],
  "extraction_metadata": {
    "timestamp": "2025-09-18T02:36:56Z",
    "extraction_confidence": "high",
    "human_validated": false,
    "notes": "Complete concept extracted from left side of PDF page 58",
    "category": "Pharmacological and Parenteral Therapies",
    "reference": "Karch, Amy, Lippincott's Nursing Drug Guide Philadelphia, Lippincott Williams and Wilkins"
  }
}